Readership
Internists, Nephrologists, Pathologists, Surgeons, Toxicologists
Scope
Renal Failure is an open access peer-reviewed journal publishing on acute renal injury and its consequences.
The primary focus of Renal Failure is acute kidney injury (AKI). This includes the basic sciences and those derived from human studies on the subject. There is a critical need to support the drive for research in this field. The high mortality of AKI in the critically ill is unacceptable. The journal aims to publish methods that have demonstrated improved outcomes of AKI in the critically ill and related research. The journal’s audience includes clinicians, researchers and medical professionals, advanced care practitioners, hospital-based pharmacists, educators, policy makers, technology developers and data scientists, and patients and patient advocates who are interested in nephrology, specifically AKI.
Renal Failure also publishes advances in the fields of chronic renal failure, hypertension and renal transplantation. The journal aims to bring together clinical and experimental aspects of renal failure to present timely, practical information on a variety of topics:
Pathology and pathophysiology of acute renal failure
Nephrotoxicity of drugs and other substances
Prevention, treatment, and therapy of renal failure
Transplantation, hypertension, and diabetes mellitus in association with renal failure
Although it does consider replication studies, the journal is focused on publishing articles with a perceived level of interest, impact, originality or significance and that will lead to developments within the field. The journal may publish negative results where these are suitably novel and interesting. Mendelian Randomization studies, database mining or data-base driven studies (e.g. NHANES), and/or predictive models will only be considered where they have clinical context and relevance. Traditional Chinese Medicine and bibliometric studies will occasionally be considered. Although the main focus of the journal is to publish research and clinical results in humans, preclinical, animal and in vitro studies may be published where they will shed light on disease processes and therapies.
Renal Failure accepts Clinical Studies, Laboratory Studies, State-of-the-Art Review Articles, Systematic Reviews, Brief Reports, Comments, Educational Comments, Article Commentaries and Editorials (Editors and Guest Advisors only) for publication. The journal operates a single-anonymized peer review policy. PRISMA guidelines are required for Systematic Reviews.